CIK 0001370053
- Non-accelerated filer
- Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 203828755
- Phone
- +1 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $17,224,593
- in 1 filing
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-05-11 | Topper James N Director | Other disposition | −1,372,000 | 973,612 | ||
| 2018-05-11 | Topper James N Director | Other acquisition | +301,024 | 301,024 | ||
| 2018-05-11 | Topper James N Director | Other disposition | −301,024 | 0 | ||
| 2018-05-11 | Topper James N Director | Other acquisition | +31,854 | 31,854 | ||
| 2018-05-11 | Frazier Healthcare VII, L.P. 10% owner | Other disposition | −1,372,000 | 973,612 | ||
| 2018-05-11 | Frazier Healthcare V, LP 10% owner | Other disposition | −1,372,000 | 973,612 | ||
| 2018-04-16 | Lydon Nicholas Director | Sale | −2,600 | $84.18 | $219K | 301,506 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −10,310 | $85.11 | $877K | 291,196 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −1,390 | $86.15 | $120K | 289,806 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −9,425 | $87.46 | $824K | 280,381 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −4,250 | $88.30 | $375K | 276,131 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −2,803 | $89.42 | $251K | 273,328 |
| 2018-04-16 | Lydon Nicholas Director | Sale | −2,222 | $90.26 | $201K | 271,106 |
| 2018-03-05 | FENTON DENNIS M Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-03-05 | FENTON DENNIS M Director | Grant or award · Director Stock Option (right to buy) | +5,507 | 5,507 | ||
| 2018-02-15 | Lydon Nicholas Director | Exercise or conversion | +16,483 | $4.55 | $75K | 304,106 |
| 2018-02-15 | Lydon Nicholas Director | Exercise or conversion · Series C Preferred Stock Warrant (right to buy) | −16,483 | 0 | ||
| 2018-02-02 | Ware J. Anthony Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-02-02 | Topper James N Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 | ||
| 2018-02-02 | Schoeneck James A Director | Grant or award · Director Stock Option (right to buy) | +6,000 | 6,000 |
Page 31 of 36 · 714 trades